Belfast, Northern Ireland 14 Oct 2024 - 15 Oct 2024
ea0104p138 | Neuroendocrinology
ea0104p139 | Neuroendocrinology
Progressive neurosarcoidosis presenting as idiopathic hypopituitarism with atypical radiological features for 13 years
ea0104p140 | Neuroendocrinology
ea0104p141 | Neuroendocrinology
ea0104p142 | Neuroendocrinology
ea0104p143 | Neuroendocrinology
ea0104p144 | Neuroendocrinology
ea0104p145 | Neuroendocrinology
ea0104p146 | Neuroendocrinology
ea0104p147 | Neuroendocrinology
ea0104p148 | Neuroendocrinology
ea0104p149 | Neuroendocrinology
ea0104p150 | Neuroendocrinology
ea0104p151 | Neuroendocrinology
ea0104p152 | Neuroendocrinology
ea0104p153 | Neuroendocrinology
ea0104p154 | Neuroendocrinology
ea0104p155 | Neuroendocrinology
ea0104p156 | Neuroendocrinology
ea0104p157 | Neuroendocrinology
ea0104p158 | Neuroendocrinology
ea0104p159 | Neuroendocrinology
ea0104p160 | Neuroendocrinology
ea0104p161 | Neuroendocrinology
ea0104p162 | Neuroendocrinology
ea0104p163 | Neuroendocrinology
ea0104p164 | Neuroendocrinology
ea0104p165 | Neuroendocrinology
ea0104p166 | Neuroendocrinology
ea0104p167 | Neuroendocrinology
DNA methylation via nanopore sequencing: will it be the future biomarker of the neuroendocrine tumour?